Prime Medicine, Inc. Quarterly Deferred Income Tax Liabilities, Net in USD from Q4 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
Prime Medicine, Inc. quarterly Deferred Income Tax Liabilities, Net history and growth rate from Q4 2021 to Q1 2024.
  • Prime Medicine, Inc. Deferred Income Tax Liabilities, Net for the quarter ending March 31, 2024 was $134K, a 74% increase year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $134K +$57K +74% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $0 -$279K -100% Dec 31, 2023 10-Q 2024-05-10
Q3 2023 $0 -$481K -100% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $108K Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $77K Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $279K -$964K -77.6% Dec 31, 2022 10-K 2024-03-01
Q3 2022 $481K Sep 30, 2022 10-Q 2022-11-14
Q4 2021 $1.24M Dec 31, 2021 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.